Mitigating Heat-induced Physiological Strain and Discomfort in Older Adults Via Lower Limb Immersion and Neck Cooling
Evaluating the Efficacy of Lower Leg Immersion With and Without Neck Cooling for Limiting Heat Strain in Elderly Adults During Extreme Heat Events
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Study Type
Study Type
Enrollment (Actual)
Enrollment
Phase
Phase
- Not Applicable
Contacts and Locations
Study Contact
Study Contact
- Name: Glen P Kenny, PhD
- Phone Number: 4282 6135625800
- Email: gkenny@uottawa.ca
Study Contact Backup
- Name: Robert D Meade, PhD
- Phone Number: 6136986071
- Email: rmead015@uottawa.ca
Study Locations
-
-
Ontario
-
Ottawa, Ontario, Canada, K1N6N5
- University of Ottawa
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Male or female adults.
- Aged 65-85 years.
- Non-smoking.
- English or French speaking.
- Ability to provide informed consent.
Exclusion Criteria:
- Physical restriction (e.g., due to disease: intermittent claudication, renal impairment, active proliferative retinopathy, unstable cardiac or pulmonary disease, disabling stroke, severe arthritis, etc.).
- Use of or changes in medication judged by the patient or investigators to make participation in this study inadvisable (e.g., medications increasing risk of heat-related illness; beta blockers, anticholinergics, etc.)
- Cardiac abnormalities identified via 12-lead ECG during an incremental exercise test to volitional fatigue (performed for all participants).
- Peak aerobic capacity (VO2peak), as measured during an incremental exercise test to volitional fatigue, exceeding the 50th percentile of age- and sex-specific normative values published by the American College of Sports Medicine (ACSM).
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Basic Science
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: Double
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Active Comparator: No cooling intervention (control)
Adults aged 65-85 years with or without type 2 diabetes and/or hypertension.
|
Participants are exposed to 38°C, 35% relative humidity for 6 hours without cooling interventions (control condition).
Drinking water is available ad libitum.
|
|
Experimental: Lower limb immersion
Adults aged 65-85 years with or without type 2 diabetes and/or hypertension.
|
Participants are exposed to 38°C, 35% relative humidity for 6 hours.
For the last 40 min of each hour, participants lower limbs are immersed in cool water (~20°C) up to the level of mid calf.
Drinking water is available ad libitum.
|
|
Experimental: Lower limb immersion + neck cooling
Adults aged 65-85 years with or without type 2 diabetes and/or hypertension.
|
Participants are exposed to 38°C, 35% relative humidity for 6 hours.
For the last 40 min of each hour, participants lower limbs are immersed in cool water (~20°C) up to the level of mid calf.
During limb immersion, a towel soaked in cool water (~20°C) is placed around the participants neck.
The towel is re-wet half way through the 40-min limb immersion.
Drinking water is available ad libitum.
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Core temperature
Time Frame: End of heat exposure (hour 6)
|
Rectal temperature measured as an index of core temperature (15 minute average)
|
End of heat exposure (hour 6)
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Heart rate
Time Frame: End of heat exposure (hour 6)
|
Heart rate derived from 3-lead electrocardiogram (15 minute average)
|
End of heat exposure (hour 6)
|
|
Systolic blood pressure
Time Frame: End of heat exposure (hour 6)
|
Systolic blood pressure measured in triplicate via automated oscillometry (~60 seconds between measures)
|
End of heat exposure (hour 6)
|
|
Diastolic blood pressure
Time Frame: End of heat exposure (hour 6)
|
Diastolic blood pressure measured in triplicate via automated oscillometry (~60 seconds between measures)
|
End of heat exposure (hour 6)
|
|
Rate pressure product
Time Frame: End of heat exposure (hour 6)
|
Rate pressure product, an index of myocardial work and strain, calculated as systolic blood pressure x heart rate.
|
End of heat exposure (hour 6)
|
|
Heart rate variability: SDNN
Time Frame: End of heat exposure (hour 6)
|
Standard deviation of normal-to-normal RR intervals (SDNN) measured during 5 minutes of paced breathing (15 breaths/min) with participants in the seated position.
SDNN will be evaluated twice, during two paced breathing periods (separated by 4 min of seated rest).
|
End of heat exposure (hour 6)
|
|
Heart rate variability: RMSSD
Time Frame: End of heat exposure (hour 6)
|
Root mean squared standard deviation of normal-to-normal RR intervals (RMSSD) measured during 5 minutes of paced breathing (15 breaths/min) with participants in the seated position.
RMSSD will be evaluated twice, during two paced breathing periods (separated by 4 min of seated rest).
|
End of heat exposure (hour 6)
|
|
Cardiac response to standing from supine (30:15 ratio)
Time Frame: End of heat exposure (hour 6)
|
Cardiac response to standing evaluated as the ratio between the highest RR interval (lowest heart rate) measured at the 30th heart beat after standing from supine (+/- 5 beats) and the lowest RR interval (highest heart rate) measured at the 15th heart beat after standing (+/- 5 beats).
Cardiac response to standing will be evaluated twice, during two lying-to-standing tests (separated by 10 min of supine rest).
|
End of heat exposure (hour 6)
|
|
Systolic response to standing from supine
Time Frame: End of heat exposure (hour 6)
|
Systolic blood pressure response to standing evaluated as the difference in blood pressure measured between the standing and supine.
Standing systolic blood pressure will be taken as the lowest value of those measured after 60 and 120 seconds of standing.
Systolic response to standing will be evaluated twice, during two lying-to-standing tests (separated by 10 min of supine rest).
|
End of heat exposure (hour 6)
|
|
Integrated baroreflex sensitivity (sit-to-stand maneuvers)
Time Frame: End of heat exposure (hour 6)
|
Determined from beat-to-beat arterial pressures and heart rate (volume-clamp technique) during 5 min of sit-to-stand maneuvers performed at 0.05 Hz (3 cycles per min; 15 total cycles).
|
End of heat exposure (hour 6)
|
|
Fluid consumption
Time Frame: End of heat exposure (hour 6)
|
Cumulative fluid consumption calculated by weighing participant water intake at the start and end of each hour of exposure.
|
End of heat exposure (hour 6)
|
|
Fluid loss
Time Frame: End of heat exposure (hour 6)
|
Fluid loss calculated as the change in body mass during each exposure presented as a percentage of baseline body mass (corrected for food consumption)
|
End of heat exposure (hour 6)
|
|
Change in plasma volume
Time Frame: End of heat exposure (hour 6)
|
Change in plasma volume from baseline values calculated from duplicate measurements of hemoglobin and hematocrit at the start and end of each exposure using the technique by Dill and Costill.
|
End of heat exposure (hour 6)
|
|
Thermal comfort
Time Frame: End of heat exposure (hour 6)
|
Thermal comfort assessed via a visual analog scale ("How comfortable does your body temperature feel?") ranging from extremely uncomfortable to extremely comfortable (midpoint: neutral).
|
End of heat exposure (hour 6)
|
|
Orthostatic intolerance symptoms assessment
Time Frame: End of heat exposure (hour 6)
|
Cumulative sum of scores on 6 questions asking participant to rank symptoms associated with orthostatic intolerance during the last 1-2 hours (including the lying-to-standing and sit-to-stand tests).
All symptoms scored on a scale from 0 (none) to 10 (worst possible) and include feelings of: (1) "dizziness, lightheadedness, feeling faint, or feeling like you might black out"; (2) "Problems with vision (blurring, seeing spots, tunnel vision, etc.)"; (3) "Weakness"; (4) "Fatigue"; (5) "Trouble concentrating"; and (6) "Head and neck discomfort".
|
End of heat exposure (hour 6)
|
Collaborators and Investigators
Sponsor
Sponsor
Investigators
Investigators
- Principal Investigator: Glen P Kenny, PhD, University of Ottawa
- Principal Investigator: Ronald J Sigal, MD, MPH, University Of Calgary
- Principal Investigator: Robert D Meade, PhD, University of Ottawa
Study record dates
Study Major Dates
Study Start (Actual)
Study Start
Primary Completion (Actual)
Primary Completion
Study Completion (Actual)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- H-11-20-6234
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
IPD Sharing Time Frame
IPD Sharing Access Criteria
IPD Sharing Supporting Information Type
- STUDY_PROTOCOL
- SAP
- ANALYTIC_CODE
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.